JRCT ID: jRCT2080225309
Registered date:12/08/2020
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer
Basic Information
| Recruitment status | recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 06/08/2020 |
| Target sample size | 6 |
| Countries of recruitment | Japan,North America,Europe,null |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Cofetuzumab Pelidotin Therapeutic category code : --- Other Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
| Primary Outcome | efficacy |
|---|---|
| Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT04189614,JapicCTI-205405 |